Table 1:
Summary of demographics and risk factors
| Total N=1481 |
|
|---|---|
| Sex | |
| Female | 646/1481 (44%) |
| Male | 835/1481 (56%) |
| Age at diagnosis, years | |
| <5 | 644/1480 (44%) |
| ≥5 to <15 | 630/1480 (43%) |
| ≥15 | 206/1480 (14%) |
| Race | |
| White | 867/1481 (59%) |
| Black | 35/1481 (2%) |
| Asian | 126/1481 (9%) |
| Other/unknown | 453/1481 (31%) |
| Ethnicity | |
| Non-Hispanic | 928/1481 (63%) |
| Hispanic | 381/1481 (26%) |
| Unknown | 172/1481 (12%) |
| Underlying malignancy | |
| Central nervous system | 457/1481 (31%) |
| Germ cell tumor | 207/1481 (14%) |
| Hepatoblastoma | 177/1481 (12%) |
| Neuroblastoma | 258/1481 (17%) |
| Osteosarcoma | 297/1481 (20%) |
| Other | 85/1481 (6%) |
| Vincristine exposure | |
| No | 673/1481 (45%) |
| Yes | 785/1481 (53%) |
| Unknown | 23/1481 (2%) |
| Cranial radiation therapy dose, Gy | |
| 0 | 1078/1454 (74%) |
| >0 to ≤50 | 56/1454 (4%) |
| >50 | 320/1454 (22%) |
| VP shunt | |
| No | 658/1481 (44%) |
| Yes | 120/1481 (8%) |
| Unknown | 703/1481 (47%) |
| Stem cell transplant | |
| No | 1046/1481 (71%) |
| Yes | 265/1481 (18%) |
| Unknown | 170/1481 (11%) |
| Carboplatin exposure | |
| No | 637/1481 (43%) |
| Yes | 219/1481 (15%) |
| Unknown | 625/1481 (42%) |